Month: July 2024

Boskalis to acquire all remaining shares in Smit Lamnalco

Written by Customer Service on July 8, 2024. Posted in Mergers And Acquisitions.

Papendrecht, 08 July 2024 Royal Boskalis B.V. (Boskalis) has signed an agreement to acquire all remaining shares (50%) in Smit Lamnalco. Smit Lamnalco offers terminal services and had an annual revenue of approximately USD 275 million and EBITDA of USD 100 million in 2023. This transaction is subject to customary conditions including the approval of regulatory authorities. FOR FURTHER INFORMATION Martijn L.D. Schuttevâer press@boskalis.com T +31 786969310Boskalis is a leading global services provider operating in the dredging, maritime infrastructure and maritime services sectors. The company provides creative and innovative all-round solutions to infrastructural challenges in the maritime, coastal and delta regions of the world. With core activities such as coastal defense, riverbank protection and land reclamation Boskalis is able...

Dassault Systèmes: declaration of the number of outstanding shares and voting rights as of June 30, 2024

Written by Customer Service on July 8, 2024. Posted in Public Companies.

Press ReleaseVELIZY-VILLACOUBLAY, France — July 8, 2024 Declaration of the number of outstanding shares and voting rights as of June 30, 2024 Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced below the total number of its outstanding shares and voting rights as of June 30, 2024, according to articles 223-16 and 221-3 of the General Regulation of the Autorité des marchés financiers. Number of outstanding shares: 1,339,093,392Number of voting rights*: 2,013,026,170 *The total number of voting rights is calculated on the basis of the total number of outstanding shares, even if the voting rights attached thereto are suspended, pursuant to Article 223-11 of the General Regulation of the Autorité des marchés financiers relating to the method for calculating the percentages of holdings in shares and in voting rights. We...

Globex Acquires Two More Highly Prospective Gold Properties

Written by Customer Service on July 8, 2024. Posted in Mergers And Acquisitions.

ROUYN-NORANDA, Quebec, July 08, 2024 (GLOBE NEWSWIRE) — GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang & Schwarz, LS Exchange, TTMzero, Düsseldorf and Quotrix Düsseldorf Stock Exchanges and GLBXF – OTCQX International in the US) wishes to inform shareholders that, through a transaction with IAMGOLD Corporation (“IAMGOLD”, IMG-TSX, IAG-NYSE), Globex has acquired two gold projects located in the Abitibi West area of Quebec. Globex has acquired the former Eldrich Gold Mine (also called Pierre Beauchemin Gold Mine) northwest of Rouyn-Noranda and the Porcupine West Gold property, west of the town of Duparquet, Quebec. The transaction saw Globex acquiring these two properties in exchange for Globex’s Rich Lake (base-metals) and Lac à l’Eau Jaune (gold) properties....

Telemedicine Market to Surpass USD 430.72 Billion by 2031, Witnessing 17.95% CAGR Growth | SkyQuest Technology

Written by Customer Service on July 8, 2024. Posted in Mergers And Acquisitions.

Westford, USA, July 08, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the Telemedicine market will attain a value of USD 430.72 billion by 2031, with a CAGR of 17.95% during the forecast period (2024-2031). The telemedicine market has been growing tremendously at an exponential rate because of the development of technology and the ever-growing demand for healthcare. It is mainly designed to enable access to health care services, increase the effectiveness of service provision, and improve the quality-of-service deliveries by mitigating the limitations created by geographic location, without necessarily overloading traditional health care facilities or increasing costs. The social distancing measures that were crafted due to the COVID-19 pandemic forced the adoption of telemedicine, which was further enhanced by grants and funding...

CN to Report Second-Quarter 2024 Financial and Operating Results on July 23, 2024

Written by Customer Service on July 8, 2024. Posted in Earnings Releases And Operating Results.

MONTREAL, July 08, 2024 (GLOBE NEWSWIRE) — CN (TSX: CNR) (NYSE: CNI) will issue its second-quarter 2024 financial and operating results after the market close on July 23, 2024. CN’s senior officers will review the results and the railway’s outlook in a conference call starting at 4:30 p.m. Eastern Time on July 23. Tracy Robinson, CN President and Chief Executive Officer, will lead the call. Parties wishing to participate via telephone may dial 1-800-715-9871 (Canada/U.S.), or 1-647-932-3411 (International), using 2135176 as the passcode. Participants are advised to dial in 10 minutes prior to the call. CN will webcast the presentation live and furnish slides supporting the officers’ remarks via the Investors section of its website at www.cn.ca/en/investors. A webcast replay will be available after the call ends. About...

Sify Technologies announces the appointment of Dr. Tom Bradicich to its Board of Directors

Written by Customer Service on July 8, 2024. Posted in Public Companies.

CHENNAI, India, July 08, 2024 (GLOBE NEWSWIRE) — Sify Technologies Limited (NASDAQ: SIFY), India’s leading Digital ICT solutions provider with global service capabilities spanning Data Center, Cloud, Networks, Security and Digital services, today announced the appointment of Dr. Tom Bradicich as the incoming Director on the Board of Sify Technologies Limited. Dr. Bradicich previously served on several boards, including that of Aspen Technology (AZPN), a publicly traded industrial software company, and the Advisory Boards of SparkCognition, an AI software company and a social media and silicon chip start-up. Dr. Bradicich’s professional career was spent in global leadership roles at Fortune 500 IT companies such as IBM and HPE where he and his team developed and launched dozens of software and systems products, received many patents,...

Qualifacts and MethodOne by Computalogic Partner to Elevate Controlled Medication Dispensing for Substance Use Disorders

Written by Customer Service on July 8, 2024. Posted in Mergers And Acquisitions.

In partnership with MethodOne by Computalogic“We are excited to partner with Qualifacts to expand access to our comprehensive controlled medication dispensing solution,” said Keith Jones, CEO of MethodOne by Computalogic. “Together, we are empowering SUD treatment providers to deliver high-quality care, improve operational efficiency, and ultimately save lives.”Nashville, Tenn., July 08, 2024 (GLOBE NEWSWIRE) — Qualifacts, the leading provider of end-to-end electronic health record (EHR) software and data solutions for behavioral healthcare organizations, and MethodOne by Computalogic, a comprehensive controlled-medication dispensing solution, announced a strategic partnership to address the escalating opioid epidemic. This collaboration integrates the award-winning EHR platforms from Qualifacts...

Quantum Computing Market Forecast to Grow at 30.7% CAGR from 2024 to 2031 | SkyQuest Technology

Written by Customer Service on July 8, 2024. Posted in Mergers And Acquisitions.

Westford, USA, July 08, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the Global Quantum Computing Market will attain a value of USD 7135 Million by 2031, with a CAGR of 30.7% during the forecast period (2024-2031). Quantum Computing, as it is known today, is the foundation of emerging technologies. Technology has witnessed multiple progresses in the past years, but a few practical barriers are still on the way. The latest success in AI and the conforming boost it gave to the traditional algorithms present an extra obstacle for quantum algorithms. Economies, such as Canada, the United States, and China made some major advances in QC and succeeded in developing quantum computers indigenously. Download a detailed overview:https://www.skyquestt.com/sample-request/quantum-computing-market Browse in-depth TOC on the “Quantum...

SELLAS Receives European Medicines Agency Orphan Drug Designation for SLS009 for the Treatment of Acute Myeloid Leukemia

Written by Customer Service on July 8, 2024. Posted in Public Companies.

NEW YORK, July 08, 2024 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced that the European Commission, based on a positive opinion issued by the European Medicines Agency (EMA), has granted Orphan Drug Designation (ODD) for SLS009, a novel, and highly selective CDK9 inhibitor, for the treatment of acute myeloid leukemia (AML). “We are thrilled to receive ODD from the EMA for the treatment of AML. This designation along with the recently announced strong preliminary Phase 2 data and previous FDA ODD designation reinforces our continued progress and commitment to developing SLS009 as a potential treatment for AML,” said Angelos Stergiou,...

Silo Pharma Announces Exclusive, Global License for Lead Candidate SPC-15 Targeting PTSD and Stress-Induced Anxiety Disorders

Written by Customer Service on July 8, 2024. Posted in Public Companies.

Extensive Issued and Pending IP Patent Applications Acquired with License Agreement SARASOTA, FL, July 08, 2024 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing novel formulations and drug delivery systems for traditional therapeutics and psychedelic treatments, today announced that it has entered into an exclusive, global license agreement with Columbia University to further develop, manufacture, and commercialize its lead drug candidate, SPC-15, an intranasal treatment for stress-induced affective disorders and PTSD. Silo recently submitted a pre-IND briefing package and meeting request for SPC-15 to the U.S. Food and Drug Administration (FDA) earlier this month. The Company is currently engaged in the final steps required before...

Month: July 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals